Expert Opinion on Biological Therapy 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.The economics of biosimilars and challenges to biosimilar adoption in low- and middle-income countries
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - August 19, 2023 Category: Drugs & Pharmacology Authors: Matthias Calamia Ivo Abraham Source Type: research
Challenges in proliferative vitreoretinopathy: is biological therapy a solution?
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - August 18, 2023 Category: Drugs & Pharmacology Authors: Lorenzo Ferro DesideriSouska ZandiMartin S ZinkernagelRodrigo Anguitaa Department of Ophthalmology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerlandb Department for BioMedical Research, University of Bern, Bern, Switzerlandc Be Source Type: research
The evolving therapeutic landscape of diabetic retinopathy
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - August 14, 2023 Category: Drugs & Pharmacology Authors: Aumer ShughouryAshay BhatwadekarDenis JusufbegovicAmir HajrasoulihaThomas A Ciullaa Department of Ophthalmology, Eugene and Marilyn Glick Eye Institute, Indiana University School of Medicine, Indianapolis, IN, USAb Retina Service, Midwest Eye Institute, M Source Type: research
Reduced doses of biological therapies in psoriasis: a new potentially “sustainable” frontier of psoriasis treatment
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - August 9, 2023 Category: Drugs & Pharmacology Authors: Simone RiberoMichela OrtoncelliLuca MastorinoPietro QuaglinoPaolo DapavoDepartment of Medical Sciences, Dermatology Clinic, University of Turin, Turin, Italy Source Type: research
Biosimilars for the next decade in Latin America: a window of opportunity
Volume 23, Issue 8, July - December 2023 . (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - August 9, 2023 Category: Drugs & Pharmacology Authors: Tomas Gabriel BasUniversidad Catolica del Norte (Chile), Escuela de Ciencias Empresariales, Coquimbo, Chile Source Type: research
Biosimilars for the next decade in Latin America: a window of opportunity
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - August 9, 2023 Category: Drugs & Pharmacology Authors: Tomas Gabriel Bas Source Type: research
Reduced doses of biological therapies in psoriasis: a new potentially “sustainable” frontier of psoriasis treatment
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - August 9, 2023 Category: Drugs & Pharmacology Authors: Simone Ribero Michela Ortoncelli Luca Mastorino Pietro Quaglino Paolo Dapavo Source Type: research
Are monoclonals the way forward to prevent or to treat ventilator-associated pneumonia in the intensive care unit?
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - July 29, 2023 Category: Drugs & Pharmacology Authors: Ana Catalina Hernandez PadillaSylvain MeyerCH Van WerkhovenMarlieke EA de KrakerBruno Fran çoisa Inserm, Limoges, Franceb Réanimation Polyvalente, CHU Dupuytren, Limoges, Francec Inserm UMR 1092 and Université of Limoges, Limoges, Franced Department of Source Type: research
The landscape of biosimilars in Saudi Arabia: preparing for the next decade
Volume 23, Issue 8, July - December 2023 . (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - July 28, 2023 Category: Drugs & Pharmacology Authors: Abdulaali R. AlmutairiAli M. Al-SamilAbdulaziz AlsayyariConsuela Cheriece YousefMansoor Ahmed KhanHani S. AlhamdanAhmed Al-Jedaia Drug Sector, Saudi Food and Drug Authority, Riyadh, Saudi Arabiab Pharmaceutical Care Department, Ministry of National Guard Source Type: research
The landscape of biosimilars in Saudi Arabia: preparing for the next decade
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - July 28, 2023 Category: Drugs & Pharmacology Authors: Abdulaali R. Almutairi Ali M. Al-Samil Abdulaziz Alsayyari Consuela Cheriece Yousef Mansoor Ahmed Khan Hani S. Alhamdan Ahmed Al-Jedai Source Type: research
The status and preparation for the next decade of biosimilars in the Middle Eastern and North African region
Volume 23, Issue 8, July - December 2023 . (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - July 26, 2023 Category: Drugs & Pharmacology Authors: Nimer S AlkhatibShiraz HalloushIvo Abrahama Faculty of Pharmacy, Al-Zaytoonah University of Jordan, Amman, Jordanb Center for Health Outcomes and PharmacoEconomic Evaluation, University of Arizona, Tucson, AZ, USAc Pi Pharma Intelligence, LLC, Amman, Jord Source Type: research
The status and preparation for the next decade of biosimilars in the Middle Eastern and North African region
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - July 26, 2023 Category: Drugs & Pharmacology Authors: Nimer S Alkhatib Shiraz Halloush Ivo Abraham Source Type: research
Preparing for the next decade of anti-VEGF biosimilars for retinal diseases: a focus on South Asia
Volume 23, Issue 8, July - December 2023 . (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - July 25, 2023 Category: Drugs & Pharmacology Authors: Ashish SharmaNilesh KumarNikulaa ParachuriAnat LoewensteinFrancesco BandelloBaruch D Kuppermanna Lotus Eye Hospital and Institute, Coimbatore, TN, Indiab Madhavi Netralaya, Ara, Bihar, Indiac Department of Vitreoretina, Sankara Eye Hospital, Coimbatore, T Source Type: research
